Pfizer Inc
NYSE:PFE

Watchlist Manager
Pfizer Inc Logo
Pfizer Inc
NYSE:PFE
Watchlist
Price: 25.8 USD 0.08% Market Closed
Market Cap: 146.7B USD

Relative Value

The Relative Value of one PFE stock under the Base Case scenario is hidden USD. Compared to the current market price of 25.8 USD, Pfizer Inc is hidden .

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

PFE Relative Value
HIDDEN
Show
Worst Case
Base Case
Best Case

Valuation Multiples

vs History
69
vs Industry
47
Median 3Y
2.4
Median 5Y
2.6
Industry
2.6
Forward
2.3
vs History
42
vs Industry
26
Median 3Y
13.2
Median 5Y
13.8
Industry
21.7
Forward
8.1
vs History
46
vs Industry
31
Median 3Y
11.8
Median 5Y
11
Industry
16.6
vs History
7
vs Industry
23
Median 3Y
11.7
Median 5Y
9.4
Industry
22.5
vs History
88
vs Industry
47
Median 3Y
1.7
Median 5Y
2
Industry
2.3
vs History
47
vs Industry
36
Median 3Y
2.9
Median 5Y
3
Industry
2.9
Forward
3
vs History
63
vs Industry
46
Median 3Y
4
Median 5Y
4.4
Industry
5.5
vs History
58
vs Industry
36
Median 3Y
7.6
Median 5Y
8
Industry
13.1
Forward
7.7
vs History
53
vs Industry
33
Median 3Y
10.4
Median 5Y
10.7
Industry
16.6
Forward
8.7
vs History
31
vs Industry
25
Median 3Y
14.2
Median 5Y
13
Industry
15.8
vs History
36
vs Industry
20
Median 3Y
19.1
Median 5Y
16
Industry
19.1
vs History
79
vs Industry
58
Median 3Y
1
Median 5Y
1.2
Industry
1.9

Multiples Across Competitors

PFE Competitors Multiples
Pfizer Inc Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
All Countries
Close
Market Cap P/S P/E EV/EBITDA EV/EBIT
US
Pfizer Inc
NYSE:PFE
146.7B USD 2.3 14.9 7.6 10.3
US
Eli Lilly and Co
NYSE:LLY
954.7B USD 16.1 51.9 34.8 37.3
UK
Dechra Pharmaceuticals PLC
LSE:DPH
440.4B GBP 578.3 -15 783.5 3 846.3 17 702.3
US
Johnson & Johnson
NYSE:JNJ
505.3B USD 5.5 20.1 16.4 21.3
CH
Roche Holding AG
SIX:ROG
253.1B CHF 4.1 26.8 11.5 13.4
UK
AstraZeneca PLC
LSE:AZN
210.8B GBP 4.9 30.1 108.4 158.7
CH
Novartis AG
SIX:NOVN
203.4B CHF 4.6 17.8 11.3 14.6
US
Merck & Co Inc
NYSE:MRK
246.3B USD 3.8 12.9 9.2 11
DK
Novo Nordisk A/S
CSE:NOVO B
1.4T DKK 4.5 13.7 9.6 11.1
IE
Endo International PLC
LSE:0Y5F
202.5B USD 87.3 -69.3 321.2 805.4
FR
Sanofi SA
PAR:SAN
101.8B EUR 1.5 7.4 6.7 6.7
P/E Multiple
Earnings Growth PEG
US
Pfizer Inc
NYSE:PFE
Average P/E: 21.7
14.9
29%
0.5
US
Eli Lilly and Co
NYSE:LLY
51.9
53%
1
UK
Dechra Pharmaceuticals PLC
LSE:DPH
Negative Multiple: -15 783.5 N/A N/A
US
Johnson & Johnson
NYSE:JNJ
20.1
29%
0.7
CH
Roche Holding AG
SIX:ROG
26.8
29%
0.9
UK
AstraZeneca PLC
LSE:AZN
30.1
38%
0.8
CH
Novartis AG
SIX:NOVN
17.8
17%
1
US
Merck & Co Inc
NYSE:MRK
12.9
15%
0.9
DK
Novo Nordisk A/S
CSE:NOVO B
13.7
4%
3.4
IE
E
Endo International PLC
LSE:0Y5F
Negative Multiple: -69.3 N/A N/A
FR
Sanofi SA
PAR:SAN
7.4
26%
0.3
EV/EBITDA Multiple
EBITDA Growth EV/EBITDA to Growth
US
Pfizer Inc
NYSE:PFE
Average EV/EBITDA: 398.5
7.6
1%
7.6
US
Eli Lilly and Co
NYSE:LLY
34.8
33%
1.1
UK
Dechra Pharmaceuticals PLC
LSE:DPH
3 846.3
36%
106.8
US
Johnson & Johnson
NYSE:JNJ
16.4
9%
1.8
CH
Roche Holding AG
SIX:ROG
11.5
4%
2.9
UK
AstraZeneca PLC
LSE:AZN
108.4
10%
10.8
CH
Novartis AG
SIX:NOVN
11.3
6%
1.9
US
Merck & Co Inc
NYSE:MRK
9.2
6%
1.5
DK
Novo Nordisk A/S
CSE:NOVO B
9.6
2%
4.8
IE
E
Endo International PLC
LSE:0Y5F
321.2
N/A N/A
FR
Sanofi SA
PAR:SAN
6.7
8%
0.8
EV/EBIT Multiple
EBIT Growth EV/EBIT to Growth
US
Pfizer Inc
NYSE:PFE
Average EV/EBIT: 1 708.4
10.3
8%
1.3
US
Eli Lilly and Co
NYSE:LLY
37.3
36%
1
UK
Dechra Pharmaceuticals PLC
LSE:DPH
17 702.3
98%
180.6
US
Johnson & Johnson
NYSE:JNJ
21.3
15%
1.4
CH
Roche Holding AG
SIX:ROG
13.4
5%
2.7
UK
AstraZeneca PLC
LSE:AZN
158.7
23%
6.9
CH
Novartis AG
SIX:NOVN
14.6
12%
1.2
US
Merck & Co Inc
NYSE:MRK
11
8%
1.4
DK
Novo Nordisk A/S
CSE:NOVO B
11.1
1%
11.1
IE
E
Endo International PLC
LSE:0Y5F
805.4
N/A N/A
FR
Sanofi SA
PAR:SAN
6.7
15%
0.4